2025 Clinician-Backed Guide: Top 5 Injectable Biologic Delivery Systems for Equine Health First Aid in Canada — ProStride APS, IRAP II, Restigen PRP, ACell VetGen, Platelet Rich Plasma Plus Kit

ProStride APS is presented as a best-in-class autologous protein solution optimized for rapid, single‑visit preparation and delivery in equine first‑aid scenarios; its balanced profile of anti‑inflammatory cytokines and growth factors gives it a technical edge for acute joint and soft‑tissue inflammation. Compared with platelet‑only systems listed here, ProStride’s APS approach can reduce downstream anti‑inflammatory medication needs and often represents a mid‑range capital outlay that balances bedside efficacy against the higher upfront costs of scaffold or cell‑based products like ACell VetGen. For field-first‑aid use it trades slightly higher kit cost for targeted biochemical activity that can shorten recovery time in many cases.

IRAP II System holds a market‑leader position for targeted anti‑inflammatory biologic injections, thanks to its focus on concentrating IL‑1 receptor antagonist and other modulators that address acute synovitis and inflammatory pain in horses. While typically priced higher than generic PRP kits, IRAP II’s mechanism gives it a clinical advantage over simple platelet concentrates for controlling destructive joint inflammation, making it a preferred option where immediate, inflammation‑focused outcomes are the priority in first‑aid treatment. Compared with scaffold‑oriented options, it is more of a short‑term anti‑inflammatory tool rather than a regenerative implant, which influences purchasing decisions for ambulatory vs. referral practices.

Restigen PRP is a platelet‑rich plasma system designed for equine protocols that prioritizes ease of use, quick centrifugation and a reliable platelet yield, making it especially suitable for field first‑aid kits where speed and repeatability matter. Financially it sits below cell‑ or scaffold‑based technologies and some APS/IRAP systems, delivering a cost‑effective boost in growth factors to accelerate soft‑tissue healing though with less specialized anti‑inflammatory specificity than IRAP II or APS. For practices that need an affordable, broadly applicable biologic for lacerations, tendon strains and minor joint support, Restigen offers a practical balance of performance and price.

ACell VetGen is positioned as the leader for extracellular matrix (ECM) scaffold and regenerative adjuncts in equine biologics, bringing a structural, regenerative approach that complements injectable plasma‑ or cytokine‑based therapies used in first‑aid. Technically more complex and typically more expensive than injectable kits, it is best deployed when a regenerative scaffold is indicated (e.g., tendon sheath or soft‑tissue defects) rather than as a rapid anti‑inflammatory first‑aid syringe; when combined with PRP or APS it can enhance long‑term tissue remodeling. Financially, practices weigh its higher per‑case cost against potential reductions in re‑intervention and improved structural healing in moderate‑to‑severe injuries.